XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Available for Sale Securities
9 Months Ended
Mar. 31, 2025
Available for Sale Securities  
Available for Sale Securities

Note 3:  Available for Sale Securities

The amortized cost, gross unrealized gains, gross unrealized losses, ACL, and approximate fair value of securities available for sale consisted of the following:

March 31, 2025

 

 

Gross

 

Gross

 

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt securities:

Obligations of states and political subdivisions

$

27,313

$

4

$

(1,918)

$

$

25,399

Corporate obligations

33,119

93

(877)

32,335

Asset-backed securities

38,240

745

(180)

38,805

Other securities

 

4,416

 

15

 

(66)

 

 

4,365

Total debt securities

103,088

857

(3,041)

100,904

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

134,178

1,110

(5,834)

129,454

Commercial MBS issued by GSEs

68,170

362

(4,820)

63,712

CMOs issued by GSEs

175,395

218

(6,753)

168,860

Total MBS and CMOs

 

377,743

 

1,690

 

(17,407)

 

362,026

Total AFS securities

$

480,831

$

2,547

$

(20,448)

$

$

462,930

June 30, 2024

 

 

Gross

 

Gross

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt securities:

Obligations of states and political subdivisions

$

29,960

$

4

$

(2,211)

$

$

27,753

Corporate obligations

32,998

60

(1,781)

31,277

Asset-backed securities

57,403

1,525

(249)

58,679

Other securities

5,387

 

20

 

(74)

 

5,333

Total debt securities

125,748

1,609

(4,315)

123,042

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

110,918

692

(6,855)

104,755

Commercial MBS issued by GSEs

65,195

297

(5,746)

59,746

CMOs issued by GSEs

148,382

82

(8,104)

140,360

Total MBS and CMOs

 

324,495

 

1,071

 

(20,705)

 

 

304,861

Total AFS securities

$

450,243

$

2,680

$

(25,020)

$

$

427,903

The amortized cost and estimated fair value of available for sale securities, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

March 31, 2025

 

Amortized

 

Estimated

(dollars in thousands)

    

Cost

    

Fair Value

Within one year

$

81

$

82

After one year but less than five years

 

28,318

 

28,060

After five years but less than ten years

 

44,990

 

43,057

After ten years

 

29,699

 

29,705

Total investment securities

 

103,088

 

100,904

MBS and CMOs

 

377,743

 

362,026

Total AFS securities

$

480,831

$

462,930

The carrying value of marketable securities pledged as collateral to secure public deposits amounted to $291.3 million and $265.5 million at March 31, 2025 and June 30, 2024, respectively. The securities pledged consisted of $148.7 million and $137.0 million of MBS, $107.3 million and $103.5 million of CMOs, $31.7 million and $20.8 million of Obligations of State and Political Subdivisions Obligations, and $3.6 million and $4.3 million of Other Securities at March 31, 2025 and June 30, 2024, respectively.

The following tables show the gross unrealized losses and fair value of the Company’s investments, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for which an ACL has not been recorded at March 31, 2025 and June 30, 2024:

March 31, 2025

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

    

Fair Value

    

Losses

    

Fair Value

    

Losses

    

Fair Value

    

Losses

(dollars in thousands)

Obligations of state and political subdivisions

$

6,083

$

84

$

15,689

$

1,834

$

21,772

$

1,918

Corporate obligations

2,918

6

18,939

871

21,857

877

Asset-backed securities

2,577

1

803

179

3,380

180

Other securities

19

3,847

66

3,866

66

MBS and CMOs

 

70,505

 

562

 

159,315

 

16,845

 

229,820

 

17,407

Total AFS securities

$

82,102

$

653

$

198,593

$

19,795

$

280,695

$

20,448

June 30, 2024

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

    

Fair Value

    

Losses

    

Fair Value

    

Losses

    

Fair Value

    

Losses

(dollars in thousands)

Obligations of state and political subdivisions

$

3,720

$

38

$

21,762

$

2,173

$

25,482

$

2,211

Corporate obligations

25,295

1,781

25,295

1,781

Asset-backed securities

7,234

249

7,234

249

Other securities

4,404

31

287

43

4,691

74

MBS and CMOs

 

56,820

 

621

 

193,382

 

20,084

 

250,202

 

20,705

Total AFS securities

$

64,944

$

690

$

247,960

$

24,330

$

312,904

$

25,020

The following information pertaining to unrealized losses and ACL on securities, by security type, is presented as of March 31, 2025.

Obligations of state and political subdivisions. The unrealized losses on the Company’s investments in obligations of state and political subdivisions include 10 individual securities which have been in an unrealized loss position for less than 12 months and 35 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Corporate and Other Obligations. The unrealized losses on the Company’s investments in corporate obligations include four securities which have been in an unrealized loss position for less than 12 months and 14 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Asset-Backed Securities. The unrealized losses on the Company’s investments in asset-backed securities include one individual security which have been in an unrealized loss position for less than 12 months and three individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized loss was caused by variations in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

MBS and CMOs. The unrealized losses on the Company’s investments in MBS and CMOs include 18 individual securities which have been in an unrealized loss position for less than 12 months, and 106 individual securities which have been in an unrealized loss position for 12 months or more. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

The Company does not believe that any individual unrealized loss as of March 31, 2025, is the result of a credit loss. However, the Company could be required to recognize an ACL in future periods with respect to its available for sale investment securities portfolio.

Credit Losses Recognized on Investments.  There were no credit losses recognized in income and other losses or recorded in other comprehensive loss for the three- or nine- month periods ended March 31, 2025 and 2024.